• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Acne Increases Suicide Risk, With or Without Accutane

Acne Increases Suicide Risk, With or Without Accutane

January 1, 2011
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Editor-in-Chief, Caroline Fisher, PhD, MD

Subject:
SUICIDE

Short Description:
Acne Increases Suicide Risk, With or Without Accutane

Background:
Despite having been around for 30 years, there is still controversy surrounding the acne drug isotretinoin (Accutane) and its association with psychiatric problems. The drug insert carries a warning that it may “rarely” cause suicidal ideation, suicide attempts, and suicide (Accutane [package insert]. Nutley, NJ: Roche Laboratories, Inc; 2010). Research has been mixed, with some finding a connection between depression and Accutane (Friedman T et al, Eur Neuropsychopharmacol 2006;16(6):413–416) and some, not so much (CH Ng and Schweitzer I, Aust N Z J Psychiatry 2003;37(1):78–84). Recently, Swedish researchers looked at this issue, this time in a retrospective study of 5,756 people, ages 15 to 49, who had taken Accutane any time between 1980 and 2001. Examination of medical and death records took place from up to three years before the start of medication until up to 15 years after completion. The mean age of patients at first prescription was 22.3 for males and 27.1 for females. Both groups took Accutane for an average of six months. In all, 128 people in this group were admitted to the hospital for suicide attempts. There were a total of 210 discharges (1.6 per person), which is explained through some patients making multiple suicide attempts. The risk of suicide attempt was greatest within the first six months of treatment (1.93 standardized incidence ratio for first attempts; 1.78 for all attempts). The risk was also higher than the general population before treatment began, with a standardized incidence ratio of 1.36 in the year before treatment. After treatment, risk of suicide began to match the general population, until the 11-year point, when it rose for repeat attempts among female patients (Sundström A et al, BMJ 2010;341:c5812).

TCPR's Take:
This research shows a correlation between suicide attempts and severe acne, but not necessarily a strong association between suicide attempts and Accutane. Among these patients, the risk of suicide attempt was slightly higher than the norm up to six months after taking Accutane, but the risk was already higher before these people ever started taking the drug—making it likely that the social and emotional pain of the acne may be more closely related to the suicide attempts than the medication used to treat it. Nonetheless, this is a lesson that patients with severe acne should be watched closely for signs of suicidality.

Child Psychiatry
KEYWORDS depressive_disorder
    www.thecarlatreport.com
    Issue Date: January 1, 2011
    SUBSCRIBE NOW
    Table Of Contents
    Neurofeedback as a Treatment for ADHD
    ADHD as an Executive Function Disorder
    Acne Increases Suicide Risk, With or Without Accutane
    Stimulants in the Treatment of ADHD
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.